Asthma and bronchodilator responsiveness are associated with polymorphic markers of ARG1, CRHR2 and chromosome 17q21

Pharmacogenetics and Genomics

Volumn 22, Issue 7, 2012, Pages 517-524

  Sy, Hing Yee ^a   Ko, Fanny W S ^a   Chu, Hong Yin ^a   Chan, Iris H S ^a   Wong, Gary W K ^a   Hui, David S C ^a   Leung, Ting Fan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

asthma; bronchodilator responsiveness; gene gene interaction; multifactor dimensionality reduction; spirometry

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MONTELUKAST; THEOPHYLLINE;

ADULT; ARGINASE 1 GENE; ARTICLE; ASTHMA; CHINESE; CHROMOSOME 17Q; CONTROLLED STUDY; CORTICOTROPIN RELEASING HORMONE RECEPTOR 2 GENE; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84862772501     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283535d91     Document Type: Article

References (37)

1. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448:470-473. (Pubitemid 47123521)
2. Galanter J, Choudhry S, Eng C, Nazario S, Rodriguez-Santana JR, Casal J, et al. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am J Respir Crit Care Med 2008; 177:1194-1200. (Pubitemid 351860927)
3. Hirota T, Harada M, Sakashita M, Doi S, Miyatake A, Fujita K, et al. Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population. J Allergy Clin Immunol 2008; 121:769-770.
4. Tavendale R, Macgregor DF, Mukhopadhyay S, Palmer CN. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J Allergy Clin Immunol 2008; 121:860-863. (Pubitemid 351471721)
5. Leung TF, Sy HY, Ng MC, Chan IH,Wong GW, Tang NL, et al. Asthma and atopy are associated with chromosome 17q21 markers in Chinese children. Allergy 2009; 64:621-628.
6. GIfA November 2006. Global Strategy for Asthma Management and Prevention; November 2006. Available at http://www.ginasthma.org [Accessed 22 April 2011].
7. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol 2008; 378:171-184.
8. Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol 2000; 130:1793-1798. (Pubitemid 30655789)
9. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999; 55:1015-1028. (Pubitemid 29361068)
10. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, et al. Systematic review and meta-analysis of the association between b2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005; 162:201-211. (Pubitemid 41373524)
11. Litonjua AA, Lasky-Su J, Schneiter K, Tantisira KG, Lazarus R, Klanderman B, et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008; 178:688-694.
12. Li H, Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Estela Del Rio-Navarro B, Kistner EO, et al. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol 2006; 117:119-126. (Pubitemid 43019225)
13. Salam MT, Islam T, Gauderman WJ, Gilliland FD. Roles of arginase variants, atopy, and ozone in childhood asthma. J Allergy Clin Immunol 2009; 123:596-602, 602 e591-e598.
14. Poon AH, Tantisira KG, Litonjua AA, Lazarus R, Xu J, Lasky-Su J, et al. Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. Pharmacogenet Genomics 2008; 18:373-382. (Pubitemid 351535938)
15. Holla LI, Schuller M, Buckova D, Vacha J. Neuronal nitric oxide synthase gene polymorphism and IgE-mediated allergy in the Central European population. Allergy 2004; 59:548-552. (Pubitemid 38580776)
16. Gao PS, Kawada H, Kasamatsu T, Mao XQ, Roberts MH, Miyamoto Y, et al. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun 2000; 267:761-763. (Pubitemid 30099397)
17. Leung TF, Liu EK, Tang NL, Ko FW, Li CY, Lam CW, et al. Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children. Clin Exp Allergy 2005; 35:1288-1294.
18. Lee YC, Cheon KT, Lee HB, KimW, Rhee YK, Kim DS. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma. Allergy 2000; 55:959-963.
19. Holla LI, Buckova D, Kuhrova V, Stejskalova A, Francova H, Znojil V, et al. Prevalence of endothelial nitric oxide synthase gene polymorphisms in patients with atopic asthma. Clin Exp Allergy 2002; 32:1193-1198. (Pubitemid 35007423)
20. Storm van's Gravesande K, Wechsler ME, Grasemann H, Silverman ES, Le L, Palmer LJ, et al. Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med 2003; 168:228-231. (Pubitemid 36920978)
21. ATS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-338. (Pubitemid 41079078)
23. Ip MS, Ko FW, Lau AC, Yu WC,Tang KS, Choo K, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest 2006; 129:384-392. (Pubitemid 43289859)
24. Conneely KN, Boehnke M. Meta-analysis of genetic association studies and adjustment for multiple testing of correlated SNPs and traits. Genet Epidemiol 2010; 34:739-746.
25. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57:289-300.
26. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-byenvironment interactions with application to nicotine dependence. Am J Hum Genet 2007; 80:1125-1137. (Pubitemid 47579348)
27. Gao X. Multiple testing corrections for imputed SNPs. Genet Epidemiol 2011; 35:154-158.
28. Bouzigon E, Corda E, Aschard H, Dizier MH, Boland A, Bousquet J, et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 2008; 359:1985-1994.
29. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363:1211-1221.
30. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003; 111:1863-1874. (Pubitemid 38057731)
31. Mabalirajan U, Ahmad T, Leishangthem GD, Joseph DA, Dinda AK, Agrawal A, et al. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010; 125:626-635.
32. Breton CV, Byun HM, Wang X, Salam MT, Siegmund K, Gilliland FD. DNA methylation in the arginase-nitric oxide synthase pathway is associated with exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med 2011; 184:191-197.
33. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 296:L911-L920.
34. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, et al. Use of regularly scheduled albuterol treatment in asthma: genotypestratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364:1505-1512. (Pubitemid 39410416)
35. Martinez FD. Safety of long-acting beta-agonists-an urgent need to clear the air. N Engl J Med 2005; 353:2637-2639. (Pubitemid 41817711)
36. Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to long acting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 2007; 370:2118-2125. (Pubitemid 350296302)
37. Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, et al. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med 2010; 181: 676-687.